Owens & Minor (OMI) Competitors $5.46 -0.02 (-0.36%) Closing price 03:59 PM EasternExtended Trading$5.43 -0.03 (-0.55%) As of 05:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock OMI vs. HSIC, MCK, COR, CAH, PAHC, AHCO, NEOG, BLFS, INMD, and KMTSShould you be buying Owens & Minor stock or one of its competitors? The main competitors of Owens & Minor include Henry Schein (HSIC), McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Phibro Animal Health (PAHC), AdaptHealth (AHCO), Neogen (NEOG), BioLife Solutions (BLFS), InMode (INMD), and Kestra Medical Technologies (KMTS). These companies are all part of the "medical" sector. Owens & Minor vs. Its Competitors Henry Schein McKesson Cencora Cardinal Health Phibro Animal Health AdaptHealth Neogen BioLife Solutions InMode Kestra Medical Technologies Owens & Minor (NYSE:OMI) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability. Is OMI or HSIC more profitable? Henry Schein has a net margin of 3.05% compared to Owens & Minor's net margin of -13.78%. Owens & Minor's return on equity of 26.59% beat Henry Schein's return on equity.Company Net Margins Return on Equity Return on Assets Owens & Minor-13.78% 26.59% 2.45% Henry Schein 3.05%14.36%5.52% Which has more risk & volatility, OMI or HSIC? Owens & Minor has a beta of 1.03, suggesting that its share price is 3% more volatile than the S&P 500. Comparatively, Henry Schein has a beta of 0.86, suggesting that its share price is 14% less volatile than the S&P 500. Do institutionals and insiders have more ownership in OMI or HSIC? 98.0% of Owens & Minor shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 3.7% of Owens & Minor shares are owned by insiders. Comparatively, 1.1% of Henry Schein shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts prefer OMI or HSIC? Owens & Minor presently has a consensus price target of $7.63, suggesting a potential upside of 39.65%. Henry Schein has a consensus price target of $76.67, suggesting a potential upside of 10.23%. Given Owens & Minor's higher possible upside, equities research analysts clearly believe Owens & Minor is more favorable than Henry Schein.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Owens & Minor 3 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.25Henry Schein 0 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.42 Which has stronger earnings & valuation, OMI or HSIC? Henry Schein has higher revenue and earnings than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOwens & Minor$10.70B0.04-$362.69M-$15.63-0.35Henry Schein$12.67B0.67$390M$3.1022.44 Does the media favor OMI or HSIC? In the previous week, Henry Schein had 16 more articles in the media than Owens & Minor. MarketBeat recorded 22 mentions for Henry Schein and 6 mentions for Owens & Minor. Owens & Minor's average media sentiment score of 1.03 beat Henry Schein's score of 1.00 indicating that Owens & Minor is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Owens & Minor 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Henry Schein 11 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryHenry Schein beats Owens & Minor on 10 of the 17 factors compared between the two stocks. Get Owens & Minor News Delivered to You Automatically Sign up to receive the latest news and ratings for OMI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OMI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OMI vs. The Competition Export to ExcelMetricOwens & MinorMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$421.73M$10.76B$5.83B$21.65BDividend YieldN/A1.84%5.25%3.51%P/E Ratio-0.3522.1175.4429.90Price / Sales0.0430.12529.8850.80Price / Cash0.6225.0937.4224.46Price / Book0.743.5711.904.62Net Income-$362.69M$212.34M$3.29B$999.91M7 Day Performance1.00%0.60%2.13%1.77%1 Month Performance17.55%4.83%9.08%7.20%1 Year Performance-62.53%-8.53%66.34%17.70% Owens & Minor Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OMIOwens & Minor4.6651 of 5 stars$5.46-0.4%$7.63+39.7%-62.0%$421.73M$10.70B-0.3523,200Positive NewsShort Interest ↑HSICHenry Schein3.7069 of 5 stars$69.58+0.8%$76.67+10.2%-0.2%$8.44B$12.67B14.9325,000Positive NewsMCKMcKesson4.5445 of 5 stars$686.44+0.8%$725.10+5.6%+39.6%$85.41B$359.05B20.5145,000News CoveragePositive NewsCORCencora4.7728 of 5 stars$291.51+0.6%$311.25+6.8%+24.8%$56.54B$293.96B18.8346,000News CoveragePositive NewsCAHCardinal Health4.983 of 5 stars$148.60-0.6%$165.93+11.7%+30.7%$35.53B$222.58B18.0657,700Positive NewsShort Interest ↑PAHCPhibro Animal Health4.463 of 5 stars$37.07-3.6%$28.40-23.4%+97.2%$1.50B$1.30B17.742,475Trending NewsAnalyst RevisionAHCOAdaptHealth4.0382 of 5 stars$9.49+2.7%$13.40+41.2%-15.8%$1.28B$3.26B18.2510,500Positive NewsNEOGNeogen3.2559 of 5 stars$5.75flat$7.50+30.4%-63.8%$1.25B$894.66M19.832,110Trending NewsBLFSBioLife Solutions2.4858 of 5 stars$25.05+0.5%$31.29+24.9%+11.7%$1.20B$82.25M-208.73440INMDInMode2.8798 of 5 stars$14.94+0.1%$18.04+20.8%-11.1%$944.34M$394.82M8.74480Positive NewsKMTSKestra Medical Technologies1.6106 of 5 stars$16.14-8.9%$27.33+69.4%N/A$828.77M$59.81M0.00300News CoveragePositive NewsInsider Trade Related Companies and Tools Related Companies Henry Schein Alternatives McKesson Alternatives Cencora Alternatives Cardinal Health Alternatives Phibro Animal Health Alternatives AdaptHealth Alternatives Neogen Alternatives BioLife Solutions Alternatives InMode Alternatives Kestra Medical Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:OMI) was last updated on 9/11/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Owens & Minor, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Owens & Minor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.